Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Douglas Earl Martin
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Allogene Therapeutics, Inc.
BioMimetic Therapeutics Inc.
BioMimetic Therapeutics Inc.
General Counsel
Avg. Two Year Performance
(17%)
Avg. Purchase Return
(8%)
Compound
41%
Avg. Sale Return
19%
Compound
Holdings:
11.06K
shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Medical Instruments & Supplies
Health Services
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions